The expected issuance of this patent further expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products based on its ...
Nutriband (NTRB) received a Notice of Allowance from the United States Patent and Trademark Office on February 3, 2025 for patent application ...
ORLANDO - Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products with a market capitalization of $74 million, announced Monday that it has received a Notice of ...
Fentanyl Act has bipartisan support from senators nationwide as it aims to permanently classify fentanyl as a Schedule I drug and impose stiffer penalties.
Both Republicans and Democrats are looking to hold drug dealers accountable for overdose deaths.
The U.S. House passed a bill by Southwest Virginia Congressman Morgan Griffith to classify fentanyl-related substances as ...